ArticlePharmaceutical research2015

Breast cancer resistance protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1) restrict oral availability and brain accumulation of the PARP inhibitor rucaparib (AG-014699).

Selvi Durmus et al.PubMed ↗Publisher ↗

No numbers read from the abstract.